253 related articles for article (PubMed ID: 21952991)
1. MutYH mutation carriers have increased breast cancer risk.
Rennert G; Lejbkowicz F; Cohen I; Pinchev M; Rennert HS; Barnett-Griness O
Cancer; 2012 Apr; 118(8):1989-93. PubMed ID: 21952991
[TBL] [Abstract][Full Text] [Related]
2. Common MUTYH mutations and colorectal cancer risk in multiethnic populations.
Lejbkowicz F; Cohen I; Barnett-Griness O; Pinchev M; Poynter J; Gruber SB; Rennert G
Fam Cancer; 2012 Sep; 11(3):329-35. PubMed ID: 22371070
[TBL] [Abstract][Full Text] [Related]
3. Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.
Rosner G; Bercovich D; Daniel YE; Strul H; Fliss-Isakov N; Ben-Yehoiada M; Santo E; Halpern Z; Kariv R
Fam Cancer; 2015 Sep; 14(3):427-36. PubMed ID: 25822476
[TBL] [Abstract][Full Text] [Related]
4. MUTYH hotspot mutations in unselected colonoscopy patients.
Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
[TBL] [Abstract][Full Text] [Related]
5. Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
Wasielewski M; Out AA; Vermeulen J; Nielsen M; van den Ouweland A; Tops CM; Wijnen JT; Vasen HF; Weiss MM; Klijn JG; Devilee P; Hes FJ; Schutte M
Breast Cancer Res Treat; 2010 Dec; 124(3):635-41. PubMed ID: 20191381
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
7. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
Rennert G; Bisland-Naggan S; Barnett-Griness O; Bar-Joseph N; Zhang S; Rennert HS; Narod SA
N Engl J Med; 2007 Jul; 357(2):115-23. PubMed ID: 17625123
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome.
Baris HN; Kedar I; Halpern GJ; Shohat T; Magal N; Ludman MD; Shohat M
Isr Med Assoc J; 2007 Dec; 9(12):847-50. PubMed ID: 18210922
[TBL] [Abstract][Full Text] [Related]
11. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
12. Frequent mutation in North African patients with MUTYH-associated polyposis.
Lefevre JH; Colas C; Coulet F; Baert-Desurmont S; Mongin C; Tiret E; Frebourg T; Soubrier F; Parc Y
Clin Genet; 2011 Oct; 80(4):389-93. PubMed ID: 21443744
[TBL] [Abstract][Full Text] [Related]
13. The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer.
Casper M; Acalovschi M; Lammert F; Zimmer V
Fam Cancer; 2014 Jun; 13(2):243-7. PubMed ID: 24420788
[TBL] [Abstract][Full Text] [Related]
14. Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer.
Elsaid A; Elshazli R; El-Tarapely F; Darwish H; Abdel-Malak C
Fam Cancer; 2017 Jan; 16(1):83-90. PubMed ID: 27631816
[TBL] [Abstract][Full Text] [Related]
15. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
Balaguer F; Castellví-Bel S; Castells A; Andreu M; Muñoz J; Gisbert JP; Llor X; Jover R; de Cid R; Gonzalo V; Bessa X; Xicola RM; Pons E; Alenda C; Payá A; Piqué JM;
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):379-87. PubMed ID: 17368238
[TBL] [Abstract][Full Text] [Related]
16. Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort.
Fulk K; LaDuca H; Black MH; Qian D; Tian Y; Yussuf A; Espenschied C; Jasperson K
Fam Cancer; 2019 Apr; 18(2):197-201. PubMed ID: 30582135
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the MYH gene do not substantially contribute to the risk of breast cancer.
Beiner ME; Zhang WW; Zhang S; Gallinger S; Sun P; Narod SA
Breast Cancer Res Treat; 2009 Apr; 114(3):575-8. PubMed ID: 18454351
[TBL] [Abstract][Full Text] [Related]
18. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E
Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035
[TBL] [Abstract][Full Text] [Related]
19. Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
Wolf I; Laitman Y; Rubinek T; Abramovitz L; Novikov I; Beeri R; Kuro-O M; Koeffler HP; Catane R; Freedman LS; Levy-Lahad E; Karlan BY; Friedman E; Kaufman B
Oncogene; 2010 Jan; 29(1):26-33. PubMed ID: 19802015
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
